Arquilla Edward R

DirectorRADIENT PHARMACEUTICALS Corp (RPC) · full profile →Form 4/A · filed Oct 19, 2009
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 14, 2009Grant(A)20K$0.75$15K20K
Oct 14, 2009Grant(A)20K$0.75$15K40K
Oct 14, 2009Grant(A)20K$0.75$15K60K
Oct 14, 2009Grant(A)20K$0.75$15K80K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-09-049041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.